These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 7822107)

  • 41. Synthesis, conformation and biological activity of dermorphin and deltorphin I analogues containing N-alkylglycine in place of residues in position 1, 3, 5 and 6.
    Biondi L; Giannini E; Filira F; Gobbo M; Marastoni M; Negri L; Scolaro B; Tomatisc R; Rocchi R
    J Pept Sci; 2003 Oct; 9(10):638-48. PubMed ID: 14620129
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of conformational properties of linear and cyclic delta selective opioid ligands DTLET (Tyr-D X Thr-Gly-Phe-Leu-Thr) and DPLPE (Tyr-c[D X Pen-Gly-Phe-Pen]) by 1H n.m.r. spectroscopy.
    Belleney J; Roques BP; Fournie-Zaluski MC
    Int J Pept Protein Res; 1987 Sep; 30(3):356-64. PubMed ID: 3692682
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Spinal antinociceptive effects of [D-Ala2]deltorphin II, a novel and highly selective delta-opioid receptor agonist.
    Improta G; Broccardo M
    Peptides; 1992; 13(6):1123-6. PubMed ID: 1362979
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antinociceptive and behavioral effects of synthetic deltorphin analogs.
    Negri L; Noviello L; Noviello V
    Eur J Pharmacol; 1996 Jan; 296(1):9-16. PubMed ID: 8720471
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential contribution of C-terminal regions of dermorphin and dermenkephalin to opioid-sites selection and binding potency.
    Sagan S; Amiche M; Delfour A; Camus A; Mor A; Nicolas P
    Biochem Biophys Res Commun; 1989 Sep; 163(2):726-32. PubMed ID: 2551274
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Conformation-activity relationships of cyclic dermorphin analogues.
    Wilkes BC; Schiller PW
    Biopolymers; 1990 Jan; 29(1):89-95. PubMed ID: 2158362
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proton NMR conformational analysis of cyclic beta-casomorphin analogues of the type Tyr-cyclo[N omega-D-Orn-Xaa-Yaa-Gly-].
    Mrestani-Klaus C; Brandt W; Schmidt R; Neubert K; Schiller PW
    Arch Pharm (Weinheim); 1996 Mar; 329(3):133-42. PubMed ID: 9005812
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pseudoproline-containing analogues of morphiceptin and endomorphin-2: evidence for a cis Tyr-Pro amide bond in the bioactive conformation.
    Keller M; Boissard C; Patiny L; Chung NN; Lemieux C; Mutter M; Schiller PW
    J Med Chem; 2001 Nov; 44(23):3896-903. PubMed ID: 11689075
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structural function of C-terminal amidation of endomorphin. Conformational comparison of mu-selective endomorphin-2 with its C-terminal free acid, studied by 1H-NMR spectroscopy, molecular calculation, and X-ray crystallography.
    In Y; Minoura K; Tomoo K; Sasaki Y; Lazarus LH; Okada Y; Ishida T
    FEBS J; 2005 Oct; 272(19):5079-97. PubMed ID: 16176278
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The aspartic acid in deltorphin I and dermenkephalin promotes targeting to delta-opioid receptor independently of receptor binding.
    Sagan S; Charpentier S; Delfour A; Amiche M; Nicolas P
    Biochem Biophys Res Commun; 1992 Sep; 187(3):1203-10. PubMed ID: 1329732
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Conformational features responsible for the binding of cyclic analogues of enkephalin to opioid receptors. III. Probable binding conformations of mu-agonists with phenylalanine in position 3.
    Shenderovich MD; Nikiforovich GV; Golbraikh AA
    Int J Pept Protein Res; 1991 Apr; 37(4):241-51. PubMed ID: 1654306
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and pharmacological activity of deltorphin and dermorphin-related glycopeptides.
    Tomatis R; Marastoni M; Balboni G; Guerrini R; Capasso A; Sorrentino L; Santagada V; Caliendo G; Lazarus LH; Salvadori S
    J Med Chem; 1997 Aug; 40(18):2948-52. PubMed ID: 9288177
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structure-activity relationships of dermorphin analogues containing N-substituted amino acids in the 2-position of the peptide sequence.
    Schmidt R; Kálmán A; Chung NN; Lemieux C; Horváth C; Schiller PW
    Int J Pept Protein Res; 1995 Jul; 46(1):47-55. PubMed ID: 7558596
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of a D-alanine-containing polypeptide precursor for the peptide opioid, dermorphin.
    Mor A; Delfour A; Nicolas P
    J Biol Chem; 1991 Apr; 266(10):6264-70. PubMed ID: 2007579
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The delta-selective opioid peptide dermenkephalin and the mu-selective hybrid peptide dermenkephalin-[1-4]-dermophin-[5-7] display strikingly different conformations despite identical tetrapeptide N-termini. A quantitative 2-D NMR and molecular modeling analysis.
    Riand J; Baron D; Nicolas P; Benajiba A; Teng Y; Naim M
    J Biomol Struct Dyn; 1999 Dec; 17(3):445-60. PubMed ID: 10636080
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative analysis of various proposed models of the receptor-bound conformation of H-Tyr-Tic-Phe-OH related delta-opioid antagonists.
    Wilkes BC; Schiller PW
    Biopolymers; 1995; 37(6):391-400. PubMed ID: 8589244
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Delta opioidmimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides.
    Salvadori S; Attila M; Balboni G; Bianchi C; Bryant SD; Crescenzi O; Guerrini R; Picone D; Tancredi T; Temussi PA
    Mol Med; 1995 Sep; 1(6):678-89. PubMed ID: 8529134
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Opioid peptides from frog skin.
    Amiche M; Delfour A; Nicolas P
    EXS; 1998; 85():57-71. PubMed ID: 9949868
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High-resolution NMR studies of fibrinogen-like peptides in solution: structural basis for the bleeding disorder caused by a single mutation of Gly(12) to Val(12) in the A alpha chain of human fibrinogen Rouen.
    Ni F; Konishi Y; Bullock LD; Rivetna MN; Scheraga HA
    Biochemistry; 1989 Apr; 28(7):3106-19. PubMed ID: 2742828
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and biological evaluation of constrained analogues of the opioid peptide H-Tyr-D-Ala-Phe-Gly-NH2 using the 4-amino-2-benzazepin-3-one scaffold.
    Ballet S; Frycia A; Piron J; Chung NN; Schiller PW; Kosson P; Lipkowski AW; Tourwé D
    J Pept Res; 2005 Nov; 66(5):222-30. PubMed ID: 16218989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.